215 Publications (Page 7 of 9)
2005
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory
Miller, Kathy⋅Miller, Kathy D⋅Soule, Sharon⋅Soule, Sharon E⋅Calley, Cynthia⋅Calley, Cynthia⋅Emerson, Robert⋅Emerson, Robert E⋅Hutchins, Gary D⋅Hutchins, Gary⋅Kopecky, Kenyon⋅Kopecky, Kenyon⋅Badve, Sunil S⋅Badve, Sunil⋅Storniolo, AnnaMaria⋅Storniolo, AnnaMaria⋅Goulet, Robert⋅Goulet, Robert⋅Sledge Jr, George and Sledge, George W
Breast Cancer Research and Treatment, vol. 89, (no. 2), pp. 187-97, Jan 2005. | Journal Article
 
Synthesis of [18F]SU11248, a new potential PET tracer for imaging cancer tyrosine kinase.
Wang, Ji-Quan⋅Miller, Kathy D⋅Sledge, George W and Zheng, Qi Huang
Bioorganic & medicinal chemistry letters, vol. 15, (no. 19), pp. 4380-4, 2005/Oct/1. | Journal Article
2004
A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.
Miller, Kathy D⋅Soule, Sharon E⋅Haney, La Trice G⋅Guiney, Patricia⋅Murry, Darryl J⋅Lenaz, Luigi⋅Sun, Show Li and Sledge, George W
Investigational New Drugs, vol. 22, (no. 1), pp. 69-73, 2004/Jan. | Journal Article
 
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
Miller, Kathy D⋅Saphner, Thomas J⋅Waterhouse, David M⋅Chen, T-T⋅Rush-Taylor, Anita⋅Sparano, Joseph A⋅Wolff, Antonio C⋅Cobleigh, Melody A⋅Galbraith, Susan and Sledge, George W
Clinical cancer research : an official journal of the American Association for Cancer Research. , vol. 10, (no. 6), pp. 1971-5, 2004/Mar/15. | Journal Article
 
Breast cancer: the role of angiogenesis and antiangiogenic therapy.
Miller, Kathy D and Dul, Carrie L
Hematology/Oncology Clinics of North America, vol. 18, (no. 5), pp. 1071-86, ix, 2004/Oct. | Journal Article
 
Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
Zheng, Qi H⋅Fei, Xiangshu⋅Liu, Xuan⋅Wang, Ji Q⋅Stone, K L⋅Martinez, Tanya D⋅Gay, Dawn J⋅Baity, Winston L⋅Miller, Kathy D⋅Sledge, George W and Hutchins, Gary D
Nuclear medicine and biology, vol. 31, (no. 1), pp. 77-85, 2004/Jan. | Journal Article
 
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer
Miller, Kathy
The Women's Oncology Review, vol. 4, (no. 3), pp. 213, September 2004. | Journal Article
 
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
Miller, Kathy D
Breast cancer research : BCR. , vol. 6, (no. 3), pp. 128-32, 2004. | Journal Article
 
Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.
Fei, Xiangshu⋅Fei, Xiangshu⋅Zheng, Qi Huang⋅Zheng, Qi-Huang⋅Wang, Ji-Quan⋅Wang, Ji-Quan⋅Stone, K Lee⋅Stone, K L⋅Martinez, Tanya D⋅Martinez, Tanya D⋅Miller, Kathy D⋅Miller, Kathy D⋅Sledge, George W⋅Sledge, George W⋅Hutchins, Gary D and Hutchins, Gary D
Bioorganic & medicinal chemistry letters, vol. 14, (no. 5), pp. 1247-51, 2004/Mar/8. | Journal Article
 
Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers.
Fei, Xiangshu⋅Wang, Ji-Quan⋅Miller, Kathy D⋅Sledge, George W⋅Hutchins, Gary D and Zheng, Qi Huang
Nuclear medicine and biology, vol. 31, (no. 8), pp. 1033-41, 2004/Nov. | Journal Article
 
Thermoacoustic in vivo determination of blood oxygenation
Kiser, William L⋅Kruger, Robert A⋅Reinecke, Daniel R⋅Kruger, Gabe A and Miller, Kathy D
Proceedings of SPIE, vol. SPIE-5320, pp. 1-7, 2004. | Journal Article
 
The role of ErbB inhibitors in trastuzumab resistance.
Miller, Kathy D
The Oncologist, vol. 9 Suppl 3, pp. 16-9, 2004. | Journal Article
 
The role of ErbB inhibitors in trastuzumab resistance.
Miller, Kathy D
The oncologist. , vol. 9 Suppl 3, pp. 16-9, 2004. | Journal Article
2003
A Convenient Procedure for the Synthesis of O6-Benzylguanine Derivatives by Phase Transfer Catalysis
Liu, Xuan⋅Liu, Xuan⋅Liu, Xuan⋅Zheng, Qi Huang⋅Zheng, Qi-Huang⋅Zheng, Qi-Huang⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Fei, Xiangshu⋅Fei, Xiangshu⋅Fei, Xiangshu⋅Erickson, Leonard C⋅Erickson, Leonard C⋅Erickson, Leonard C⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Mock, Bruce H⋅Mock, Bruce H⋅Mock, Bruce H⋅Glick-Wilson, Barbara E⋅Glick-Wilson, Barbara E⋅Glick-Wilson, Barbara E⋅Winkle, Wendy L⋅Winkle, Wendy L⋅Winkle, Wendy L⋅Lee Stone, K⋅Lee Stone, K⋅Lee Stone, K⋅Carlson, Kathy A⋅Carlson, Kathy A and Carlson, Kathy A
Synthetic Communications, vol. 33, (no. 6), pp. 952, 1/4/2003. | Journal Article
 
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Cobleigh, Melody A⋅Langmuir, Virginia K⋅Sledge, George W⋅Miller, Kathy D⋅Haney, Latrice⋅Novotny, William F⋅Reimann, James D and Vassel, Amy
Seminars in oncology, vol. 30, (no. 5 Suppl 16), pp. 117-24, 2003/Oct. | Journal Article
 
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.
Miller, Kathy D
Clinical Breast Cancer, vol. 3, (no. 6), pp. 421-2, 2003/Feb. | Journal Article
 
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lu, Ming⋅Lu, Ming⋅Miller, Kathy⋅Miller, Kathy D⋅Gokmen Polar, Yesim⋅Gokmen-Polar, Yesim⋅Jeng, Meei-Huey⋅Jeng, Meei-Huey⋅Kinch, Michael S and Kinch, Michael
Cancer research, vol. 63, (no. 12), pp. 3425-9, 2003/Jun/15. | Journal Article
 
Exploiting the hallmarks of cancer: the future conquest of breast cancer.
Sledge, George W and Miller, Kathy D
European Journal of Cancer, vol. 39, (no. 12), pp. 1668-75, 2003/Aug. | Journal Article
 
Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.
Kumar, Suresh⋅Kishimoto, Hiromitsu⋅Chua, Hui L⋅Badve, Sunil S⋅Miller, Kathy D⋅Bigsby, Robert M and Nakshatri, Harikrishna
The American journal of pathology, vol. 163, (no. 6), pp. 2531-41, 2003/Dec. | Journal Article
 
Interleukin-1α Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer
Kumar, Suresh⋅Kumar, Suresh⋅Kumar, Suresh⋅Kishimoto, Hiromitsu⋅Kishimoto, Hiromitsu⋅Kishimoto, Hiromitsu⋅Chua, Hui Lin⋅Chua, Hui Lin⋅Chua, Hui Lin⋅Badve, Sunil⋅Badve, Sunil⋅Badve, Sunil⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Bigsby, Robert M⋅Bigsby, Robert M⋅Bigsby, Robert M⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna and Nakshatri, Harikrishna
The American Journal of Pathology, vol. 163, (no. 6), pp. 2541, 2003. | Journal Article
 
NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
Helbig, Gregory⋅Helbig, Gregory⋅Helbig, Gregory⋅Christopherson, 2nd, Kent W⋅Christopherson, 2nd, Kent W⋅Christopherson, Kent W⋅Bhat-Nakshatri, Poornima⋅Bhat-Nakshatri, Poornima⋅Bhat-Nakshatri, Poornima⋅Kumar, Suresh⋅Kumar, Suresh⋅Kumar, Suresh⋅Kishimoto, Hiromitsu⋅Kishimoto, Hiromitsu⋅Kishimoto, Hiromitsu⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Broxmeyer, Hal E⋅Broxmeyer, Hal E⋅Broxmeyer, Hal E⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna and Nakshatri, Harikrishna
The Journal of biological chemistry, vol. 278, (no. 24), pp. 21631-8, 2003/Jun/13. | Journal Article
 
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
Miller, Kathy D⋅Weathers, T⋅Haney, L G⋅Timmerman, R⋅Dickler, M⋅Shen, J and Sledge, George W
Annals of Oncology, vol. 14, (no. 7), pp. 1072-7, 2003/Jul. | Journal Article
 
Phase II Trial of Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Trial 1597
Masters, Gregory⋅Declerck, Lieven⋅Blanke, Charles⋅Sandler, Alan⋅DeVore, Russell⋅Miller, Kathy and Johnson, David
Journal of Clinical Oncology, vol. 21, (no. 8), pp. 1555, 20030415. | Journal Article
 
Resistance in the anti-angiogenic era: nay-saying or a word of caution?
Sweeney, Christopher J⋅Miller, Kathy D and Sledge, George W
Trends in molecular medicine. , vol. 9, (no. 1), pp. 24-9, 2003/Jan. | Journal Article
 
Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng, Qi Huang⋅Fei, Xiangshu⋅De Grado, Timothy⋅Wang, Ji-Quan⋅Stone, K L⋅Martinez, Tanya D⋅Gay, Dawn J⋅Baity, Winston L⋅Mock, Bruce H⋅Glick-Wilson, Barbara E⋅Sullivan, Michael L⋅Miller, Kathy D⋅Sledge, George W and Hutchins, Gary D
Nuclear medicine and biology, vol. 30, (no. 7), pp. 753-60, 2003/Oct. | Journal Article